Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing oral buprenorphine and injectable buprenorphine for opioid use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine (injectable) (buprenorphine)
  • Buprenorphine (oral) (buprenorphine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Opioid Use Disorder | Phase 4 | Status: RECRUITING